Patent application number | Description | Published |
20110210596 | ONE-PIECE SEAT STRUCTURE AND COLD FORMING PROCESSES TO CREATE SEAT STRUCTURES - A one-piece seat structure for use in a vehicle seat assembly comprising a first portion having a first set of characteristics; a second portion having a second set of characteristics; wherein the first set of characteristics differs from the second set of characteristics and wherein the number of portions within the same one piece structure can be multiple; and wherein the one-piece seat structure is formed from a tailored welded blank or monolithic blank using a cold forming process with optional additional post forming processes including post form heat treatment, edge treatment, and the like. | 09-01-2011 |
20120193965 | ONE-PIECE SEAT BOTTOM CHASSIS - A seat bottom chassis includes a pair of brackets configured to support a seat back chassis, and a cushion pan extending between the pair of brackets. The seat bottom chassis is formed from a single piece of material. | 08-02-2012 |
20120267935 | ONE-PIECE SEAT STRUCTURES AND METHOD OF FORMING - A one-piece seat back frame for use in a vehicle seat assembly including a first side portion, a second side portion, an upper cross portion, a lower cross portion coupled together to form a rectangular unitary frame structure. The seat back frame also includes an inner wall extending from a front surface and an inner edge of the back frame, and an outer wall extending from the front surface and an outer edge of the back frame, thereby forming a channel on the front surface. A plurality of formations are formed in the back frame to enhance the strength and stiffness of the back frame. The seat back frame also includes a plurality of apertures for attaching other seat components, such as a head restraint assembly. The seat back frame is formed from at least one of a monolithic blank, a tailored welded blank, and/or a tailored welded coil. | 10-25-2012 |
20120306253 | ONE-PIECE SEAT BACK FRAME ASSEMBLY AND METHOD OF MAKING SAME - A one-piece seat back frame for use in a vehicle seat assembly. The one-piece seat back frame includes a first side portion and a second side portion spaced apart from the first side portion, an upper cross portion and a lower cross portion. A lower cross bracket member is coupled to the seat back frame such that the lower cross bracket member at least partially overlaps the seat back frame lower cross portion forming a boxed section. A first recliner mechanism is coupled to the second end of the lower cross bracket member for a single-sided recliner system. A pivot bracket or a second recliner mechanism is coupled to the first end of the lower cross bracket member for a dual-sided recliner system. | 12-06-2012 |
20130161992 | ONE-PIECE SEAT BACK STRUCTURE - A seat back structure includes a web extending about a central opening, and an inner flange extending about an inner perimeter of the web adjacent to the central opening. The seat back structure also includes an outer flange extending about an outer perimeter of the web. The inner flange, the outer flange and the web form a channel extending about the seat back structure, and the seat back structure is formed from a single piece of material. | 06-27-2013 |
Patent application number | Description | Published |
20140140894 | POLYOLEFIN PRODUCTION WITH MULTIPLE POLYMERIZATION REACTORS - A polyolefin production system including: a first reactor configured to produce a first discharge slurry having a first polyolefin; a second reactor configured to produce a second discharge slurry having a second polyolefin; and a post-reactor treatment zone having at least a separation vessel configured to receive the second discharge slurry or both the first discharge slurry and the second discharge slurry. | 05-22-2014 |
20140171601 | POLYETHYLENE PRODUCTION WITH MULTIPLE POLYMERIZATION REACTORS - A system and method for discharging a transfer slurry from a first polymerization reactor through a transfer line to a second polymerization reactor, the transfer slurry including at least diluent and a first polyethylene. A product slurry is discharged from the second polymerization reactor, the product slurry including at least diluent, the first polyethylene, and a second polyethylene. The velocity, pressure drop, or pressure loss due to friction in the transfer line is determined, and a process variable adjusted in response to the velocity, pressure drop, or pressure loss not satisfying a specified value. | 06-19-2014 |
20140171602 | POLYETHYLENE PRODUCTION WITH MULTIPLE POLYMERIZATION REACTORS - A technique for polymerizing ethylene on catalyst in a first polymerization reactor and in a second polymerization reactor to form polyethylene particles, and controlling particle size of the polyethylene particles. | 06-19-2014 |
20140171603 | CHAIN TRANSFER AGENT REMOVAL BETWEEN POLYOLEFIN POLYMERIZATION REACTORS - A system and method for polymerizing olefin in the presence of a chain transfer agent in a first reactor to form a first polyolefin, discharging from the first reactor a transfer slurry having the first polyolefin and the chain transfer agent, and processing the transfer slurry in a separator to remove chain transfer agent and to provide a fluff slurry having the first polyolefin and a lower content of chain transfer agent than in the transfer slurry. The system and method provide for feeding the fluff slurry to a second reactor, polymerizing olefin in the second reactor to form a second polyolefin, and discharging from the second reactor a slurry having the second polyolefin. | 06-19-2014 |
20140275450 | POLYOLEFIN PRODUCTION WITH DIFFERENT DILUENTS IN MULTIPLE POLYMERIZATION REACTORS - A system and method for producing polyolefin, including a polyolefin reactor system having: a first reactor to produce a first reactor discharge stream having a first polyolefin and a first diluent; and a second reactor to receive at least a portion of the first reactor discharge stream and to produce a second reactor discharge stream having a second polyolefin and a second diluent, wherein the second diluent is different than the first diluent. | 09-18-2014 |
20140309382 | POLYOLEFIN PRODUCTION WITH DIFFERENT DILUENTS IN MULTIPLE POLYMERIZATION REACTORS - A system and method for producing polyolefin, including a polyolefin reactor system having: a first reactor to produce a first reactor discharge stream having a first polyolefin and a first diluent; and a second reactor to receive at least a portion of the first reactor discharge stream and to produce a second reactor discharge stream having a second polyolefin and a second diluent, wherein the second diluent is different than the first diluent. | 10-16-2014 |
20150126693 | CHAIN TRANSFER AGENT REMOVAL BETWEEN POLYOLEFIN POLYMERIZATION REACTORS - A system and method for polymerizing olefin in the presence of a chain transfer agent in a first reactor to form a first polyolefin, discharging from the first reactor a transfer shiny having the first polyolefin and the chain transfer agent, and processing the transfer slurry in a separator to remove chain transfer agent and to provide a fluff slurry having the first polyolefin and a lower content of chain transfer agent than in the transfer slurry. The system and method provide for feeding the fluff slurry to a second reactor, polymerizing olefin in the second reactor to form a second polyolefin, and discharging from the second reactor a slurry having the second polyolefin. | 05-07-2015 |
20150353652 | CHAIN TRANSFER AGENT REMOVAL BETWEEN POLYOLEFIN POLYMERIZATION REACTORS - A system and method for polymerizing olefin in the presence of a chain transfer agent in a first reactor to form a first polyolefin, discharging from the first reactor a transfer slurry having the first polyolefin and the chain transfer agent, and processing the transfer slurry in a separator to remove chain transfer agent and to provide a fluff slurry having the first polyolefin and a lower content of chain transfer agent than in the transfer slurry. The system and method provide for feeding the fluff slurry to a second reactor, polymerizing olefin in the second reactor to form a second polyolefin, and discharging from the second reactor a slurry having the second polyolefin. | 12-10-2015 |
20160024231 | POLYETHYLENE PRODUCTION WITH MULTIPLE POLYMERIZATION REACTORS - A system and method for discharging a transfer slurry from a first polymerization reactor through a transfer line to a second polymerization reactor, the transfer slurry including at least diluent and a first polyethylene. A product slurry is discharged from the second polymerization reactor, the product slurry including at least diluent, the first polyethylene, and a second polyethylene. The velocity, pressure drop, or pressure loss due to friction in the transfer line is determined, and a process variable adjusted in response to the velocity, pressure drop, or pressure loss not satisfying a specified value. | 01-28-2016 |
Patent application number | Description | Published |
20140314661 | Diagnostic System for the Detection of Skin Cancer - Methods and compositions are provided for the analysis of skin surfaces to determine the presence of neoplastic tissue. In the methods of the invention, a composition comprising a florescent probe that binds to a specific neoplasia associated marker is applied topically to the area of interest. After topical administration, the probe preferentially binds to markers associated in neoplastic lesions in situ, which binding is detected with a compact illumination unit that provides illumination at a wavelength appropriate for image acquisition. The illumination unit comprises a light source and fiber optic bundle to direct the light towards the area of examination. A detection unit is used to capture and record an image of the area of investigation. The detection unit may be a digital camera, film camera, etc. A mapping module may also be provided to catalogue the site of examination. | 10-23-2014 |
20140350395 | System for Imaging Lesions Aligning Tissue Surfaces - Methods, compositions and systems are provided for the imaging of cavity/tissue lesions, including without limitation cavity/tissue malignant lesions, e.g. cancers of the skin, mouth, colon, digestive system cervix, bladder, lung, etc. | 11-27-2014 |
Patent application number | Description | Published |
20130331672 | APPLICATION OF ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY IN SENSOR SYSTEMS, DEVICES, AND RELATED METHODS - A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters. | 12-12-2013 |
20130331674 | APPLICATION OF ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY IN SENSOR SYSTEMS, DEVICES, AND RELATED METHODS - A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters. | 12-12-2013 |
Patent application number | Description | Published |
20080241158 | Human taste-specific receptor TIR3 - The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC. | 10-02-2008 |
20090274680 | Human Phospholipases - The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LME. | 11-05-2009 |
Patent application number | Description | Published |
20080287394 | Hiv Integrase Inhibitors - Hydroxy-substituted pyrazinopyrrolopyridazine dione compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dione compounds are of Formula (I) wherein R | 11-20-2008 |
20100056516 | 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS - 1-Hydroxy naphthyridine compounds (e.g., 1-hydroxy naphthyridin-2(1H)-one compounds of Formula I are inhibitors of HIV integrase and/or HIV RNase H and inhibitors of HIV replication: (I) wherein X and R1-R6 are as defined herein. The compounds are useful in the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other anti-HIV agents such as HIV antivirals, immunomodulators, antibiotics and vaccines. | 03-04-2010 |
20120220571 | HIV INTEGRASE INHIBITORS - Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: (I), wherein X is O or N(R3); and R1, R2, R3 and Y are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset or progression of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se (or as hydrates or solvates thereof) or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. | 08-30-2012 |
20130053386 | DIARYL ETHER DERIVATIVES AS NOTCH SPARING GAMMA SECRETASE INHIBITORS - The invention encompasses a novel class of diaryl ether derivatives which inhibit the processing of APP by the putative γ-secretase while sparing Notch signaling pathway, and thus are useful in the treatment or prevention of Alzheimer's disease without the development of Notch inhibition mediated gastrointestinal issues. Pharmaceutical compositions and methods of use are also included. | 02-28-2013 |
20140200197 | HIV PROTEASE INHIBITORS - The compounds encompassed by Formula I include compounds which are HIV protease inhibitors and other compounds which can be metabolized in vivo to HIV protease inhibitors. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. | 07-17-2014 |